Drug Target Review: Potential target found for tuberous sclerosis complex
A study on tuberous sclerosis complex has expanded the knowledge of the formation of this disease and how it can be targeted at the molecular level.
These findings were published in the jounal Nature Metabolism.
Related Stories
New approach could treat cancer by rearranging tumor cell structures
November 10, 2025
The University of Cincinnati’s Jiajie Diao, PhD, and colleagues have published new research showing a proof of concept that rearranging the location of lipid droplets within cells can increase the effectiveness of cell starvation, making it a potential cancer treatment. The research was published as the November cover story in the journal Trends in Biotechnology.
Silicon Valley is closely watching UC’s NEXT Innovation Scholars
November 7, 2025
The University of Cincinnati’s NEXT Innovation Scholars program has built a network of elite Silicon Valley talent that’s seeking out undergraduate Bearcats and sharing insights with them.
Two University of Cincinnati colleges benefit from $4 million gift
November 7, 2025
University of Cincinnati alumni Mohammad H. Qayoumi, MS ’79, MS ’80, MBA ’84, PhD ’83 and Najia Karim, BS ’82, MEd ’83, RD, have made a $4 million gift supporting two of the university’s colleges. A donation from the couple establishes a fund and an endowed chair at the College of Engineering and Applied Science, as well as an endowed chair at the College of Allied Health Sciences.